Overview
Xiao-dan Liu practices practicing medicine in Qingyuan, China.
Their clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Placental Insufficiency, and Langerhans Cell Histiocytosis.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiao-dan Liu
Is Xiao-dan Liu a top-rated expert for Reticulohistiocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Xiao-dan Liu is classified as an Experienced expert for Reticulohistiocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiao-dan Liu participate in research or clinical trials?
Yes. Xiao-dan Liu has published 10 articles and abstracts on conditions like Reticulohistiocytoma. You can view a list of Xiao-dan Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HistiocytosisLiu isExperienced. Learn about Histiocytosis.
- Langerhans Cell Histiocytosis
- Placental InsufficiencyLiu isExperienced. Learn about Placental Insufficiency.
- ReticulohistiocytomaLiu isExperienced. Learn about Reticulohistiocytoma.